Results of HLA class I typing in 2021

Trials | Specimen | Resolution | HLA-A | No. of labs | HLA-B | No. of labs | HLA-C | No. of labs |
---|---|---|---|---|---|---|---|---|

1st | IHL-21-01 | Generic type | A*31/A*33 | 66 | B*35/B*44 | 66 | C*03/C*14 | 38 |

Allelic type | A*31:01/A*33:03 | 24 | B*35:01/B*44:03 | 25 | C*03:03/C*14:03 | 24 | ||

A*31:01/A*33:03G | 4 | B*35:01G/B*44:03G | 3 | C*03:03G/C*14:03G | 3 | |||

Serological equivalent | A31/A33 | 65 | B35/B44 | 65 | Cw9/Blank | 34 | ||

Cw9/Cw1 | 1 | |||||||

Cw9/Cw14 | 3 | |||||||

IHL-21-02 | Generic type | A*02/Blank | 66 | B*35/B*40 | 66 | C*04/C*08 | 38 | |

Allelic type | A*24:02/A*24:02 | 2 | B*35:01/B*40:06 | 25 | C*04:01/C*08:01 | 24 | ||

A*24:02/A*99:99 | 23 | B*35:01G/B*40:06G | 3 | C*04:01G/C*08:01G | 3 | |||

A*24:02G/A*24:02G | 3 | |||||||

Serological equivalent | A2/Blank | 1 | B35/B61 | 65 | Cw4/Cw8 | 38 | ||

A24/Blank | 64 | |||||||

2nd | IHL-21-03 | Generic type | A*02/A*24 | 67 | B*07/B*37 | 67 | C*06/C*07 | 39 |

Allelic type | A*02:01/A*24:01 |
1 | B*07:02/B*37:01 | 28 | C*06:02/C*07:02 | 26 | ||

A*02:01/A*24:02 | 27 | B*07:02G/B*37:01G | 3 | C*06:02G/C*07:02G | 3 | |||

A*02:01G/A*24:02G | 3 | |||||||

Serological equivalent | A2/A24 | 65 | B7/B37 | 65 | Cw6/Cw7 | 38 | ||

IHL-21-04 | Generic type | A*02/A*33 | 67 | B*54/B*55 | 67 | C*01/Blank | 39 | |

Allelic type | A*02:01/A*33:03 | 27 | B*54:01/B*55:02 | 28 | C*01:02/C*01:02 | 3 | ||

A*02:01/A*33:03G | 1 | B*54:01G/B*55:02G | 3 | C*01:02/C*99:99 | 23 | |||

A*02:01G/A*33:03G | 3 | C*01:02G/C*01:02G | 2 | |||||

C*01:02G/C*99:99 | 1 | |||||||

Serological equivalent | A2/A33 | 65 | B54/B55 | 65 | Cw1/Blank | 38 |

Bold letter indicates the results which are not compliant with the intended responses.

Abbreviation: HLA, human leukocyte antigen.

Lab Med Qual Assur 2024;46:1~37 https://doi.org/10.15263/jlmqa.2024.46.1.1

© Lab Med Qual Assur

© 2019. Laboratory Medicine and Quality Assurance. / Powered by INFOrang Co., Ltd